This inventor holds 1 USPTO granted patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Martha Liliana Serrano Serrano - Innovator in Cancer Therapy
Introduction
Martha Liliana Serrano Serrano is an inventor based in Ormalingen, Switzerland. She is known for her work in the field of cancer treatment, particularly focusing on innovative combination therapies. Her research aims to enhance the effectiveness of cancer therapies through novel approaches.
Latest Patent Applications
Martha has filed a patent application titled "COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHIBITORS." This invention relates to combination therapies that employ PD-1 axis binding antagonists and LRRK2 inhibitors. The application outlines the use of these combination therapies for the treatment of cancer.
Conclusion
Martha Liliana Serrano Serrano is a promising inventor whose work in cancer therapy could lead to significant advancements in treatment options. Her innovative approach to combining therapies showcases her commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile